Our findings indicate that BAP31 expression is significantly associated with the stages of bladder cancer (BLCA), colon cancer (COAD), renal chromophobe cell carcinoma (KICH), renal papillary cell carcinoma (KIRP), rectal adenocarcinoma (READ), and thyroid cancer (THCA) (see Figure 1B–G). Here, BCAP31 is linked to thyroid cancer.